tachycardia semaglutide causing events in afib patients? Higher-Dose Semaglutide Injection Proves Mettle

Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction

Consistent with this finding, no improvement in glucose tolerance was observed during an intraperitoneal glucose tolerance test in C57BL6 mice that were administered a subcutaneous dose of PF-06882961 (10 mg/kg) (Fig

Are there any synergistic research opportunities when studying 5-Amino-1MQ and Tesofensine

Clinic administrators should facilitate information sharing between prescribing physicians, nurses, and pharmacists

Likewise, as patients progress and require triple therapy, these medication classes comprise options in combination with a variety of other antihyperglycemic medication classes